Table 1. Enhancement of Lactoferrin uptake in cells by GAPDH.
Cell type | Fold change in Lactoferrin MFI of cells internalizing both GAPDH and Lf vs. only lactoferrin +ve cells |
---|---|
Mouse Enterocytes | 5.52* |
Mouse Hepatocytes | 4.28* |
Mouse Bone Marrow cells | 3.7* |
Mouse Spleen Macrophages | 2.1* |
Mouse Peritoneal Macrophages (Ex vivo) | 1.17* |
Mouse peritoneum cells (In-Vivo) | 6.1* |
Human Lymphocytes | 1.27* |
J774 | 2.62* |
PMA activated THP1 | 2.07* |
Non activated THP1 | No significant uptake of Lf |
CHO | 4.95* |
CHO-TRVb | 2.83* |
K562 | 1.6* |
Neuro-2A (N2A) | 4.02* |
Relative trafficking of Lf by sGAPDH as compared to surface receptors. 5 × 105 cells were incubated at 37 °C for 30 minutes with either; (i.) only lactoferrin Alexa-633 (5 μg), (ii.) only GAPDH-FITC (10 μg) or (iii.) both (i.) & (ii.). After internalization cells were washed, pronase treated and analyzed by FACS. A two-color quadrant analysis was done to see relative trafficking as described in methods, *p < 0.001 compared to Lf internalized via surface receptors only. n = 104 cells in each case.